GlassScriptPhysician profile
Christopher G Seeker
NPI 1255349528
$19,243.00
in general payments reported to CMS, 2019-2025
60 companies · $2,257 in 2025
The $2,257 reported for 2025 was more than what 95% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,105 · 2020: $3,326 · 2021: $2,767 · 2022: $2,200 · 2023: $2,261 · 2024: $2,329 · 2025: $2,257.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,822 · Education: $24.64.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,821.56 |
| Education | $24.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,213.98 | 2021-2025 | Ligasure, Truclear, V-Loc 180 |
| Abbvie INC. | $2,171.09 | 2019-2025 | Ubrelvy, Synthroid, Lo Loestrin Fe |
| Novo Nordisk INC | $2,007.54 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Asensus Surgical, INC. | $1,552.72 | 2019-2020 | |
| Pfizer INC. | $996.49 | 2019-2025 | |
| Therapeuticsmd, INC. | $987.84 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $867.50 | 2022-2025 | |
| Allergan, INC. | $842.72 | 2019-2020 | |
| Covidien LP | $663.77 | 2019-2020 | |
| Lupin INC. | $537.09 | 2019-2020 | |
| Exeltis, USA INC. | $526.95 | 2019-2025 | Slynd |
| Sumitomo Pharma America, INC. | $509.91 | 2023-2025 | Gemtesa, Myfembree |
| Hologic Sales and Service, LLC | $446.45 | 2019-2025 | Myosure Tissue Removal Device, Novasure |
| Astellas Pharma US INC | $439.50 | 2019-2025 | Veozah, Myrbetriq |
| Dysis Medical, INC. | $385.50 | 2021-2022 |
Show all 60 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Seeker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.